Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01422486 · ClinicalTrials.gov registry record · Phase 2
Phase 2 Study of Telintra® in Deletion 5q Myelodysplastic Syndrome
A Phase 2 study, sponsored by Telik.
- Terminated
- Registry status
- Phase 2
- Development phase
- 2
- Enrollment target
NCT01422486: Clinical Trial Phase 2 study, sponsored by Telik.
NCT01422486 is a Phase 2 study that was terminated before completion, run by Telik. The registered enrollment target is 2 participants, below the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (98% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01422486, a Phase 2 study, was terminated before completion, sponsored by Telik.
- TERMINATED
- Registry status
- Phase 2
- Development phase
- 2 participants
- Enrollment target
Study Summary
Study TLK199.2107 is a multicenter, single arm, open-label Phase 2 study of oral ezatiostat (Telintra®) in patients with lenalidomide (Revlimid®) refractory or resistant, red blood cell (RBC) transfusion-dependent, Low to Intermediate-1 IPSS risk, del5q Myelodysplastic Syndrome (MDS).
Primary Outcome
Hematologic Improvement response will be assessed per the IWG MDS response criteria (2006)
Interventions
- DRUG ezatiostat hydrochloride (Telintra®)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2 participants |
| Start Date | 2011-10 |
| Est. Completion | 2013-02 |
| Phase | Phase 2 |
Why NCT01422486 stopped before completion
NCT01422486 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 2 participants, a relatively small participant target, below the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (98% lower).
The record links to 0 conditions, and to 1 intervention - of which ezatiostat hydrochloride (Telintra®) is the first listed.
NCT01422486 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01422486 about?
NCT01422486 is a clinical study titled "Phase 2 Study of Telintra® in Deletion 5q Myelodysplastic Syndrome". Study TLK199.2107 is a multicenter, single arm, open-label Phase 2 study of oral ezatiostat (Telintra®) in patients with lenalidomide (Revlimid®) refractory or resistant, red blood cell (RBC) transfusion-dependent, Low to Intermediate-1 IPSS risk, del5q Myelodysplastic Syndrome (MDS).
What is the current status of trial NCT01422486?
This trial is currently terminated. It is a Phase 2 study. The enrollment target is 2 participants. The study started on 2011-10. Estimated completion is 2013-02.
What interventions are being tested in trial NCT01422486?
The interventions under investigation include: ezatiostat hydrochloride (Telintra®) (DRUG).
Who is sponsoring clinical trial NCT01422486?
This trial is sponsored by Telik, which has 21 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01422486's enrollment target sits among peer trials
2 2001st of 2000 the lowest of 2,000 other Phase 2 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 2 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia